Cargando…

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis

BACKGROUND: Astodrimer Gel contains a novel dendrimer intended to treat and prevent bacterial vaginosis. We assessed the efficacy and safety of Astodrimer Gel for treatment of bacterial vaginosis. METHODS: 132 women with bacterial vaginosis were randomized 1:1:1:1 to Astodrimer 0.5% (N = 34), 1% (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waldbaum, Arthur S., Schwebke, Jane R., Paull, Jeremy R. A., Price, Clare F., Edmondson, Stephanie R., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197797/ https://www.ncbi.nlm.nih.gov/pubmed/32365097 http://dx.doi.org/10.1371/journal.pone.0232394

Ejemplares similares

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2021)

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
por: Castellarnau, Alex, et al.
Publicado: (2022)

Astodrimer sodium and bacterial vaginosis: a mini review
por: Mendling, Werner, et al.
Publicado: (2022)

Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
por: Paull, Jeremy R.A., et al.
Publicado: (2021)

Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
por: Paull, Jeremy R. A., et al.
Publicado: (2021)

A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2015)

Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study
por: Chavoustie, Steven E., et al.
Publicado: (2015)

Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
por: Romanowski, Eric G., et al.
Publicado: (2021)

Pilot Study to Evaluate the Appropriate Management of Patients With Coexistent Bacterial Vaginosis and Cervicitis
por: Schwebke, Jane R., et al.
Publicado: (1995)

A Phase I Randomized Placebo Controlled Trial of the Safety of 3% SPL7013 Gel (VivaGel®) in Healthy Young Women Administered Twice Daily for 14 Days
por: Cohen, Craig R., et al.
Publicado: (2011)

OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
por: Fraser, Graeme, et al.
Publicado: (2019)

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial
por: Archer, David F., et al.
Publicado: (2019)

Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis
por: Muzny, Christina A., et al.
Publicado: (2013)

A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause
por: Fraser, Graeme L., et al.
Publicado: (2020)

Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study
por: Schwebke, Jane R., et al.
Publicado: (2020)

Safety and Efficacy of an Intravaginal Prebiotic Gel in the Prevention of Recurrent Bacterial Vaginosis: A Randomized Double-Blind Study
por: Coste, Isabelle, et al.
Publicado: (2012)

Correction: Characterization of the Vaginal Microbiota among Sexual Risk Behavior Groups of Women with Bacterial Vaginosis
por: Muzny, Christina A., et al.
Publicado: (2013)

Efficacy of Vitamin C Vaginal Tablets as Prophylaxis for Recurrent Bacterial Vaginosis: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
por: Krasnopolsky, Vladislav N., et al.
Publicado: (2013)

El Escultor
por: McCloud, Scott
Publicado: (2015)

Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis
por: Ruiz-Perez, Daniel, et al.
Publicado: (2021)

Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)
por: Santoro, Nanette, et al.
Publicado: (2020)

Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
por: Larsson, Per-Göran, et al.
Publicado: (2008)

Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial
por: Bradshaw, Catriona S., et al.
Publicado: (2012)

High Throughput Extraction of Plant, Marine and Fungal Specimens for Preservation of Biologically Active Molecules
por: McCloud, Thomas G.
Publicado: (2010)

Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis
por: Ravel, Jacques, et al.
Publicado: (2013)

2408 Genital microbiomes of women with recurrent bacterial vaginosis and their regular male sexual partner
por: Muzny, Christina A., et al.
Publicado: (2018)

Financial stress and mental health among higher education students in the UK up to 2018: rapid review of evidence
por: McCloud, Tayla, et al.
Publicado: (2019)

Class, race and ethnicity and information avoidance among cancer survivors
por: McCloud, R F, et al.
Publicado: (2013)

SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
por: Price, Clare F., et al.
Publicado: (2011)

Tinidazole in the treatment of bacterial vaginosis
por: Armstrong, Nicola R, et al.
Publicado: (2010)

Diaphragm Used with Replens Gel and Risk of Bacterial Vaginosis: Results from a Randomized Controlled Trial
por: Cohen, Craig R., et al.
Publicado: (2012)

A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis
por: Mauck, Christine K, et al.
Publicado: (2022)

Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial
por: Heczko, Piotr B., et al.
Publicado: (2015)

Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole
por: Bohbot, Jean-Marc, et al.
Publicado: (2010)

Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial
por: Khazaeian, Somayyeh, et al.
Publicado: (2018)

An NTP-driven mechanism for the nucleotide addition cycle of Escherichia coli RNA polymerase during transcription
por: Johnson, Ronald S., et al.
Publicado: (2022)

Bacterial vaginosis
por: Hay, Phillip
Publicado: (2017)

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis
por: Armstrong-Buisseret, Lindsay, et al.
Publicado: (2019)

Double-Blinded Randomized Pilot Clinical Trial Comparing Cognitive Side Effects of Standard Ultra-Brief Right Unilateral ECT to 0.5 A Low Amplitude Seizure Therapy (LAP-ST)
por: Youssef, Nagy A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t4g74guum8r65n12d0u8h5i3at